We are live on ! Find out more
BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Fund
S&P 500
This Quarter Est. Return
-13.11%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$117M
Cap. Flow
-$78.6M
Cap. Flow %
-30.89%
Top 10 Hldgs %
62.02%
Holding
34
New
6
Increased
12
Reduced
–
Closed
16

Top Buys

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$16.5M
2
INCY icon
Incyte
INCY
+$16.2M
3
ISRG icon
Intuitive Surgical
ISRG
+$15.3M
4
BIIB icon
Biogen
BIIB
+$14M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$13.1M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$20.1M
2
AET
Aetna Inc
AET
+$19.1M
3
HUM icon
Humana
HUM
+$19.1M
4
HNT
HEALTH NET INC
HNT
+$16.4M
5
VTRS icon
Viatris
VTRS
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 86.38%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
1
Edwards Lifesciences
EW
$47.6B
$21.4M 8.41%
904,104
+413,136
+84% +$9.97M
PRGO icon
2
Perrigo
PRGO
$1.4B
$18.1M 7.1%
115,000
+30,000
+35% +$5.5M
COO icon
3
Cooper Companies
COO
$13.7B
$17.9M 7.02%
480,000
+75,080
+19% +$3.11M
INCY icon
4
Incyte
INCY
$23.5B
$16M 6.27%
+144,710
New +$16.2M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$14.7M 5.76%
139,164
+44,499
+47% +$5.94M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$121B
$14.4M 5.65%
138,138
+23,138
+20% +$2.97M
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$14.1M 5.52%
89,884
+20,294
+29% +$3.7M
CPHD
8
DELISTED
Cepheid Inc
CPHD
$14M 5.48%
308,909
+103,845
+51% +$5.54M
ISRG icon
9
Intuitive Surgical
ISRG
$121B
$13.8M 5.41%
+270,000
New +$15.3M
NUVA
10
DELISTED
NuVasive, Inc.
NUVA
$13.7M 5.4%
285,000
+135,000
+90% +$6.98M
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
$12.9M 5.08%
+150,000
New +$13.1M
BKD icon
12
Brookdale Senior Living
BKD
$3.62B
$12.9M 5.05%
+560,220
New +$16.5M
CNC icon
13
Centene
CNC
$31.3B
$12.8M 5.04%
473,008
+51,352
+12% +$1.72M
BIIB icon
14
Biogen
BIIB
$29.9B
$12.4M 4.87%
+42,500
New +$14M
NKTR icon
15
Nektar Therapeutics
NKTR
$2.39B
$12.1M 4.73%
73,333
+11,666
+19% +$2.06M
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
$11.9M 4.66%
565,000
+215,000
+61% +$5.36M
QGENF
17
DELISTED
QIAGEN NV
QGENF
$11M 4.31%
425,000
+60,590
+17% +$1.56M
CERN
18
DELISTED
Cerner Corp
CERN
$10.8M 4.24%
+180,000
New +$11.8M
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.25B
– –
-300,000
Closed -$12.6M
ALKS icon
20
Alkermes
ALKS
$8.82B
– –
-187,500
Closed -$12.1M
CI icon
21
Cigna
CI
$76.6B
– –
-124,312
Closed -$20.1M
HUM icon
22
Humana
HUM
$46.7B
– –
-100,000
Closed -$19.1M
SNN icon
23
Smith & Nephew
SNN
$12.9B
– –
-275,000
Closed -$9.34M
TEVA icon
24
Teva Pharmaceuticals
TEVA
$35.9B
– –
-175,000
Closed -$10.3M
VTRS icon
25
Viatris
VTRS
$20.1B
– –
-240,000
Closed -$16.3M
1
2

Similar funds

BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
RJA
Robshaw & Julian Associates Williamsville, New York $140M AUM 13.69% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return
ACPVT
ABS Capital Partners V Trust Baltimore, Maryland $123M AUM
SFA
Staton Financial Advisors Charlotte, North Carolina $118M AUM 11.07% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
KFS
Kissinger Financial Services Hunt Valley, Maryland $100M AUM 6.22% 1-Year Est. Return
FHC
First Houston Capital Houston, Texas $100M AUM 23.45% 1-Year Est. Return

Blue Jay Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Blue Jay Capital Management held 34 positions worth $255M, down 31% from $372M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Blue Jay Capital Management withdrew a net $78.6M in Q3 2015, closing 16 positions. Its most notable exit was Cigna, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 79% a quarter earlier, followed by Financials.

Against the trend, Blue Jay Capital Management opened a new position in Brookdale Senior Living worth $12.9M.

  • Blue Jay Capital Management's largest Q3 2015 buy was Brookdale Senior Living: 560,220 shares worth $12.9M.
  • Blue Jay Capital Management added most to Edwards Lifesciences in Q3 2015, an estimated $9.97M increase.
  • Blue Jay Capital Management fully exited Cigna in Q3 2015, selling an estimated $20.1M.
  • Blue Jay Capital Management's ten largest holdings make up 62% of its $255M portfolio in Q3 2015.
  • Blue Jay Capital Management opened 6 new positions and closed 16 in Q3 2015.
  • Blue Jay Capital Management's portfolio value fell 31% quarter-over-quarter to $255M.

Based on Blue Jay Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.